Immunohistochemical characterization of microglia in Nasu-Hakola disease brains

Neuropathology

Volumn 31, Issue 4, 2011, Pages 363-375

  Satoh, Jun ichi ^a   Tabunoki, Hiroko ^a   Ishida, Tsuyoshi ^d   Yagishita, Saburo ^e   Jinnai, Kenji ^f   Futamura, Naonobu ^f   Kobayashi, Michio ^g   Toyoshima, Itaru ^h   Yoshioka, Toshiaki ^h   Enomoto, Katsuhiko ^h   Arai, Nobutaka ^b   Arima, Kunimasa ^c  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^d 1 7 1 Kohnodai   (Japan)

^e KANAGAWA REHABILITATION CENTER   (Japan)

^f Hyogo Cyuo National Hospital   (Japan)

^g National Hospital Organization Akita National Hospital Yurihonjo   (Japan)

^h AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bioinformatics; DAP12; Microglia; Nasu Hakola disease; TREM2

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; BIOLOGICAL MARKER; C TERMINAL BINDING PROTEIN 2; CASPASE 3; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; RAP2B PROTEIN; RAS PROTEIN; SIALIC ACID BINDING IG LIKE LECTIN 1; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTROCYTOSIS; AUTOSOMAL RECESSIVE DISORDER; BRAIN; BRAIN CORTEX; BRAIN DISEASE; CASE REPORT; CONTROLLED STUDY; DEMYELINATION; DENDRITIC CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; MACROPHAGE; MALE; MEMBRANOUS LIPODYSTROPHY; MICROARRAY ANALYSIS; MICROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ADULT; AGED; BRAIN; COMPUTATIONAL BIOLOGY; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LECTINS; LIPODYSTROPHY; MALE; MEMBRANE GLYCOPROTEINS; MICROGLIA; MIDDLE AGED; OSTEOCHONDRODYSPLASIAS; RECEPTORS, IMMUNOLOGIC; SUBACUTE SCLEROSING PANENCEPHALITIS;

EID: 79960719774     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2010.01174.x     Document Type: Article

References (35)

1. Nasu T, Tsukahara Y, Terayama K. A lipid metabolic disease -"Membranous lipodystrophy"- an autopsy case demonstrating numerous peculiar membrane-structures composed of compound lipid in bone and bone marrow and various adipose tissues. Acta Pathol Jpn 1973; 23: 539-558.
2. Hakola HP. Neuropsychiatric and genetic aspects of a new hereditary disease characterized by progressive dementia and lipomembranous polycystic osteodysplasia. Acta Psychiatr Scand Suppl 1972; 232: 1-173.
3. Bianchin MM, Capella HM, Chaves DL etal. Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy - PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects. Cell Mol Neurobiol 2004; 24: 1-24.
4. Tanaka J. Nasu-Hakola disease: a review of its leukoencephalopathic and membranolipodystrophic features. Neuropathology 2000; 20: S25-S29.
5. Kaneko M, Sano K, Nakayama J, Amano N. Nasu-Hakola disease: the first case reported by Nasu and review. Neuropathology 2010; 30: 463-470. DOI: 10.1111/j.1440-1789.2010.01127.x.
6. Paloneva J, Manninen T, Christman G etal. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am J Hum Genet 2002; 71: 656-662.
7. Klünemann HH, Ridha BH, Magy L etal. The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2. Neurology 2005; 64: 1502-1507.
8. Turnbull IR, Colonna M. Activating and inhibitory functions of DAP12. Nat Rev Immunol 2007; 7: 155-161.
9. Kaifu T, Nakahara J, Inui M etal. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest 2003; 111: 323-332.
10. Hamerman JA, Tchao NK, Lowell CA, Lanier LL. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat Immunol 2005; 6: 579-586.
11. Roumier A, Béchade C, Poncer JC etal. Impaired synaptic function in the microglial KARAP/DAP12-deficient mouse. J Neurosci 2004; 24: 11421-11428.
12. Nataf S, Anginot A, Vuaillat C etal. Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages. Am J Pathol 2005; 166: 275-286.
13. Otero K, Turnbull IR, Poliani PL etal. Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin. Nat Immunol 2009; 10: 734-743.
14. Schmid CD, Sautkulis LN, Danielson PE etal. Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia. J Neurochem 2002; 83: 1309-1320.
15. Sessa G, Podini P, Mariani M etal. Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia. Eur J Neurosci 2004; 20: 2617-1628.
16. Thrash JC, Torbett BE, Carson MJ. Developmental regulation of TREM2 and DAP12 expression in the murine CNS: implications for Nasu-Hakola disease. Neurochem Res 2009; 34: 38-45.
17. Stefano L, Racchetti G, Bianco F etal. The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor. J Neurochem 2009; 110: 284-294.
18. Hsieh CL, Koike M, Spusta SC etal. A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J Neurochem 2009; 109: 1144-1156.
19. Takahashi K, Rochford CD, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 2005; 201: 647-657.
20. Kiialainen A, Veckman V, Saharinen J etal. Transcript profiles of dendritic cells of PLOSL patients link demyelinating CNS disorders with abnormalities in pathways of actin bundling and immune response. J Mol Med 2007; 85: 971-983.
21. Satoh JI, Tabunoki H, Yamamura T. Molecular network of the comprehensive multiple sclerosis brain-lesion proteome. Mult Scler 2009; 15: 531-541.
22. Imai Y, Kohsaka S. Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia 2002; 40: 164-174.
23. Perry VH, Crocker PR, Gordon S. The blood-brain barrier regulates the expression of a macrophage sialic acid-binding receptor on microglia. J Cell Sci 1992; 101: 201-207.
24. Paloneva J, Autti T, Raininko R etal. CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts. Neurology 2001; 56: 1552-1558.
25. Schmid CD, Melchior B, Masek K etal. Differential gene expression in LPS/IFNgamma activated microglia and macrophages: in vitro versus in vivo. J Neurochem 2009; 109 (Suppl 1): 117-125.
26. Prada I, Ongania GN, Buonsanti C, Panina-Bordignon P, Meldolesi J. Triggering receptor expressed in myeloid cells 2 (TREM2) trafficking in microglial cells: continuous shuttling to and from the plasma membrane regulated by cell stimulation. Neuroscience 2006; 140: 1139-1148.
27. Takegahara N, Takamatsu H, Toyofuku T etal. Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nat Cell Biol 2006; 8: 615-622.
28. Turnbull IR, Gilfillan S, Cella M etal. Cutting edge: TREM-2 attenuates macrophage activation. J Immunol 2006; 177: 3520-3524.
29. Piccio L, Buonsanti C, Cella M etal. Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation. Brain 2008; 131: 3081-3091.
30. Piccio L, Buonsanti C, Mariani M etal. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol 2007; 37: 1290-1301.
31. Frank S, Burbach GJ, Bonin M etal. TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia 2008; 56: 1438-1447.
32. Gaikwad S, Larionov S, Wang Y etal. Signal regulatory protein-β1: a microglial modulator of phagocytosis in Alzheimer's disease. Am J Pathol 2009; 175: 2528-2539.
33. Moestrup SK, Møller HJ. CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann Med 2004; 36: 347-354.
34. Husemann J, Loike JD, Anankov R, Febbraio M, Silverstein SC. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 2002; 40: 195-205.
35. Fujita D, Terada S, Ishizu H etal. Immunohistochemical examination on intracranial calcification in neurodegenerative diseases. Acta Neuropathol 2003; 105: 259-264.